Matrix Mediated Viral Gene Delivery: A Review

被引:10
|
作者
Steinhaufft, Douglas [1 ,3 ]
Ghandehari, Hamidreza [1 ,2 ,3 ]
机构
[1] Univ Utah, Dept Biomed Engn, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA
[3] Nano Inst Utah, Utah Ctr Nanomed, 36 South Wasatch Dr, Salt Lake City, UT 84112 USA
基金
美国国家卫生研究院;
关键词
ELASTINLIKE PROTEIN POLYMER; MESENCHYMAL STEM-CELLS; IN-VIVO EVALUATION; ADENOASSOCIATED VIRUS SEROTYPE-2; LOCALIZED LENTIVIRUS DELIVERY; BONE MORPHOGENETIC PROTEIN-7; MATURE VACCINIA VIRUS; CONTROLLED-RELEASE; RECOMBINANT ADENOVIRUS; FIBRIN SCAFFOLD;
D O I
10.1021/acs.bioconjchem.8b00853
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Polymeric matrices inherently protect viral vectors from preexisting immune conditions, limit dissemination to off-target sites, and can sustain vector release. Advancing methodologies in development of particulate based vehicles have led to improved encapsulation of viral vectors. Polymeric delivery systems have contributed to increasing cellular transduction, responsive release mechanisms, cellular infiltration, and cellular signaling. Synthetic polymers are easily customizable, and are capable of balancing matrix retention with cellular infiltration. Natural polymers contain inherent biorecognizable motifs adding therapeutic efficacy to the incorporated viral vector. Recombinant polymers use highly conserved motifs to carefully engineer matrices, allowing for precise design including elements of vector retention and responsive release mechanisms. Composite polymer systems provide opportunities to create matrices with unique properties. Carefully designed matrices can control spatiotemporal release patterns that synergize with approaches in regenerative medicine and antitumor therapies.
引用
收藏
页码:384 / 399
页数:16
相关论文
共 50 条
  • [41] Optimization of Viral Gene Therapy for Inherited Retinal Diseases Using Fibrin-Mediated Delivery
    Berger, Aubrey
    Knudsen, Travis
    Iezzi, Raymond
    Zenti, Francesca
    Scruggs, Brittni
    Marmorstein, Alan D.
    MOLECULAR THERAPY, 2024, 32 (04) : 44 - 44
  • [42] Sustained Transgene Expression with Non-viral Gene Transfer Following Chitosan Mediated Delivery
    Oliveira, Ana Vanessa
    Silva, Gabriela
    Chung, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [43] Dendrimer-Grafted PLGA Nanofibrous Matrix-Mediated Gene Delivery Systems
    Peng, Qing-Yan
    Xiao, Shi-Li
    Tan, Xiao-dong
    Yang, Kai
    Wang, Yuan-Feng
    Yang, Tao
    Wang, Dan
    Hu, Shi
    Xiong, Xiao-Man
    Venkataraman, Mohanapriya
    Militky, Jiri
    TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM (TBIS) PROCEEDINGS, 2020, 2020, : 152 - 158
  • [44] Non-viral gene delivery: vehicle and delivery characterization
    Lollo, CP
    Kwoh, DY
    Mockler, TC
    Ley, PM
    Guido, MS
    Coffin, CC
    Aleman, R
    Bartholomew, RM
    Carlo, DJ
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S31 - S38
  • [45] Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review
    Habibizadeh, Mina
    Lotfollahzadeh, Shima
    Mahdavi, Parisa
    Mohammadi, Soheila
    Tavallaei, Omid
    HELIYON, 2024, 10 (16)
  • [46] Non-viral gene delivery to the lungs
    Kinsey, BM
    Densmore, CL
    Orson, FM
    CURRENT GENE THERAPY, 2005, 5 (02) : 181 - 194
  • [47] Comparing Viral Vectors for Gene Therapy Delivery
    Mirasol, Feliza
    BIOPHARM INTERNATIONAL, 2024, 37 (07)
  • [48] Viral vectors for gene delivery to the inner ear
    Maguire, Casey A.
    Corey, David P.
    HEARING RESEARCH, 2020, 394
  • [49] Gene delivery with synthetic (non viral) carriers
    Brown, MD
    Schätzlein, AG
    Uchegbu, IF
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 229 (1-2) : 1 - 21
  • [50] Non-viral gene delivery systems
    Davis, ME
    CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (02) : 128 - 131